Baird Medical Investment Holdings (BDMD) Total Non-Current Liabilities (2023 - 2025)
Baird Medical Investment Holdings (BDMD) recorded quarterly Total Non-Current Liabilities of $6.1 million in Q4 2025, up 3.65% quarter-over-quarter from $5.9 million in Q2 2025, and up 70.82% on a YoY basis from $3.6 million in Q4 2024.
Baird Medical Investment Holdings (BDMD) Total Non-Current Liabilities (2023 - 2025) Analysis & Trends
Baird Medical Investment Holdings' Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $6.1 million for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities rose 70.82% year-over-year to $6.1 million; the TTM figure through Dec 2025 stood at $6.1 million (up 70.82% YoY), while the FY2025 annual figure was $6.1 million, up 70.82% from the prior year.
- Total Non-Current Liabilities was $6.1 million for Q4 2025 at Baird Medical Investment Holdings, up from $5.9 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $6.1 million in Q4 2025 to a low of $2.0 million in Q4 2023.
- Historically, Total Non-Current Liabilities has averaged $4.4 million across 3 years, with a median of $4.7 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities surged 76.69% in 2024, then jumped 70.82% in 2025.
- A 3-year view of Total Non-Current Liabilities shows it stood at $2.0 million in 2023, then soared by 76.69% to $3.6 million in 2024, then jumped by 70.82% to $6.1 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $6.1 million (Q4 2025), $5.9 million (Q2 2025), and $3.6 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 2.44 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 24.21 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 3.53 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Baird Medical Investment Holdings | - | - | - | 6.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.11 Mn |
| Jun 30, 2025 | 5.90 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 2.03 Mn |